Legal entity
All 2 tracked stories fall under one category: regulation. #WeCount report is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. They are better corroborated than the beat average, carrying 12.5 original sources each against 3.4 for the same window.
Last mentioned: Jun 28, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 2 tracked stories fall under one category: regulation. #WeCount report is the most frequent co-covered peer, appearing in 1 of the 2 tracked stories. They are better corroborated than the beat average, carrying 12.5 original sources each against 3.4 for the same window. That works out to roughly 0.1 stories per week across a 108-day span. At 7.5, the average consequence score sits above the same-window beat average of 6.5. telehealth appears in 2 tracked Legal stories published from March 13, 2026 through June 28, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 782 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering telehealth. Shared-story counts are live from our verified record — not editorial picks.
Federal Appeals Court Bans Mailing Mifepristone
A federal appeals court made it illegal to mail mifepristone, a key medication abortion pill, threatening telehealth access.
Supreme Court Issues Stay on Mifepristone Ban
The Supreme Court stayed the appeals court ruling, allowing mailing to continue while the legal challenge proceeds.
Missouri Stay Request
DOJ files request in Missouri court to pause litigation pending FDA review.
Legislative Action
Senator Josh Hawley introduces a Senate bill to outright ban the abortion pill.
Louisiana Request
DOJ asks Louisiana court to pause a similar lawsuit; request is largely ignored by the state.
Amended Complaint
AG Catherine Hanaway files amended complaint targeting mail-order abortion drugs.
Lawsuit Filed
Missouri, Kansas, and Idaho file suit against the FDA over mifepristone approval.
Supreme Court Overturns Roe v. Wade in Dobbs Decision
The landmark ruling eliminated the constitutional right to abortion, allowing states to enact bans.
Despite state bans, U.S. abortions nearly doubled, fueled by telehealth pill delivery across state lines. This exposes legal tensions between state authority, FDA preemption, and 19th-century obscenity statutes.
The U.S. Department of Justice has requested federal courts in Missouri to pause litigation challenging the FDA's approval of mifepristone, citing an ongoing internal agency review. This tactical shift suggests a preference for administrative rulemaking over high-profile court battles as the administration navigates the legal complexities of reproductive health regulation.
Source: Danielle Han (us) · yahoo.com
telehealth is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
